Pharmaceutical Technology - May 2022

Pharmaceutical Technology- May 2022

Issue link:

Contents of this Issue


Page 52 of 63

52 Pharmaceutical Technology TRENDS IN MANUFACTURING 2022 eBOOK P h a r mTe c h . c o m Combination Products T he global biopharma market has experienced a remarkable period of evolution and expansion. In that time, parenteral medications have become one of the industry's most im- portant innovation and growth drivers. Fueled by a continuing shift toward at-home, self-administered care—an established trend accelerated by the COVID-19 pandemic— the rapid surge in demand for injectable therapies is set to continue in the coming years. Between 2020 and 2027, sales of parenteral medica- tions are projected to expand from 53–57% of global market volume, with most of those gains taken away from oral drugs (1). But with that growth comes changing expectations. As many more drug developers are discovering, demand for injectable therapies isn't simply growing; it's shifting rapidly toward products that maximize patient-centricity and support value-based at-home care models. For manufacturers, this shift means that sustainable market success often lies beyond conventional vial- and syringe-based formats. Today, optimizing injectable therapies for convenience, simplicity, and safety means ultimately converting them to patient-friendly formats such as pens, autoinjectors, and wearable delivery devices—an undertak- ing that adds multiple layers of complexity to the fill/finish workflow. While these formats may make administration and adherence easier for users, they require manufacturers to simultaneously tackle all the technical, logistic, and regulatory challenges of both aseptic filling and delivery device assembly. As always, organizations that proactively plan ahead will be best positioned to succeed with one of the most complex and challenging Converting Injectable Therapies to Combination Drug-Device Products Markus Hörburger The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices. Markus Hörburger is product and service manager Secondary Packaging & Device Assembly at Vetter. M.DÖRR & M.FROMMHERZ - STOCK.ADOBE.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2022 - Pharmaceutical Technology- May 2022